Get the Stockscreener App
4.58
0.87%
-0.04
Apimeds Pharmaceuticals US, Inc. stock is traded at $4.58, with a volume of 235.94K.
It is down -0.87% in the last 24 hours and up +179.27% over the past month.
See More
Previous Close:
$4.62
Open:
$4.6
24h Volume:
235.94K
Relative Volume:
0.02
Market Cap:
$6.91M
Revenue:
Net Income/Loss:
P/E Ratio:
-
EPS:
-
Net Cash Flow:
1W Performance:
-16.88%
1M Performance:
+179.27%
6M Performance:
-75.64%
1Y Performance:
-76.10%
1-Day Range:
$0.00
$0.00
1-Week Range:
$4.25
$6.0356
52-Week Range:
$1.51
$59.70
Apimeds Pharmaceuticals US, Inc. Stock (APUS) Company Profile
Compare APUS vs TAK, TEVA, HLN, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
APUS
Apimeds Pharmaceuticals US, Inc.
|
4.58 | 6.91M | 0 | 0 | 0 | 0.00 |
TAK
Takeda Pharmaceutical Co Adr
|
19.64 | 62.73B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
41.26 | 48.12B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.965 | 43.82B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
78.69 | 32.52B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
549.00 | 23.55B | 3.17B | 1.29B | 1.01B | 27.09 |
Apimeds Pharmaceuticals US, Inc. Stock (APUS) Latest News
MindWave Innovations Signs 3 Client Network Agreements in 10 Days, Extending MindChain into Climate Finance, Sports Media and Insurance; Apimeds Pharmaceuticals US Provides Required NYSE American Disclosure - GlobeNewswire Inc.
$Apimeds Pharmaceuticals (APUS.US)$ - Moomoo
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Why Did Apimeds (NYSEAMERICAN:APUS) Skyrocket 42.5 Percent? - kalkine.ca
$Apimeds Pharmaceuticals (APUS.US)$[Worship] - Moomoo
Why Is Apimeds Pharmaceuticals Stock Gaining Monday? - Benzinga
APUS Stock Whipsaws After Huge Run, Drawing Day Traders - Timothy Sykes
APUS Stock Whipsaws As Traders Zero In On Volatility And Cash Burn - StocksToTrade
APUS Stock Whipsaws As Traders Target Extreme Volatility - Timothy Sykes
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
MindWave Innovations Signs Agreement with US-Based - GlobeNewswire
MindWave Innovations Signs Agreement With US-Based BlockAssure to Build and Operate AssureChain, an End-to-End Insurance and Reinsurance Network - Moomoo
Apimeds Pharmaceuticals USErick Frim Resig - Moomoo
Form 8K Apimeds Pharmaceuticals US For: 1 October By Investing.com - Investing.com Nigeria
Apimeds Pharmaceuticals appoints Eric Sherb as chief financial officer - Investing.com
APUS Stock Quote Price and Forecast - CNN
Form 8K Apimeds Pharmaceuticals US For: 29 September By Investing.com - Investing.com Nigeria
Form 8K Apimeds Pharmaceuticals US For: 29 September By Investing.com - Investing.com India
Apimeds Pharmaceuticals US inks two 12-month MindChain service deals for AQUAEChain and FlashChain - TradingView
Environmental credits and match tickets feature in two new deals for Apimeds Pharmaceuticals (APUS). - Stock Titan
Apimeds Pharmaceuticals US (NYSE American: APUS) Subsidiary MindWave Innovations Signs 12-Month Agreement to Build FlashChain - The Globe and Mail
MindWave Innovations Expands U.S. Commercial Footprint with Second Agreement to Build and Operate FlashChain for New York-Based Flash Sports & Media - The Manila Times
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Apimeds Pharmaceuticals US (NYSE American: APUS) Subsidiary MindWave Signs 12-Month Technology Services Agreement with AQUAE Holdings - theglobeandmail.com
APUS Stock Volatility Explodes As Traders Pile Into Momentum - StocksToTrade
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
APUS Stock Volatility Spikes As Traders Target Breakout - timothysykes.com
APUS Stock Whipsaws As Traders Chase Parabolic Pharma Move - StocksToTrade
Meta, Everpure, Akamai Technologies, Apimeds Pharmaceuticals and Costco: Why These 5 Stocks Are on Invest - Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Trending Stocks Today | Apimeds Pharmaceuticals Surges 157.64% - moomoo.com
APUS Interactive Stock Chart | Apimeds Pharmaceuticals US, Inc Stock - finance.yahoo.com
Apimeds Pharmaceuticals Stock Skyrockets Thursday: What's Happening? - Benzinga
Dow Tumbles Over 100 Points; US Jobless Claims Fall to 197,000 - Benzinga
APUS Stock Rockets On Heavy Volume As Traders Hunt Volatility - timothysykes.com
APUS Stock Explodes Higher As Traders Target Volatile Breakout - StocksToTrade
Form 8K Apimeds Pharmaceuticals US For: 23 September By Investing.com - Investing.com Nigeria
IBN Initiates Coverage of Apimeds Pharmaceuticals US, Inc. - GlobeNewswire
Apimeds Pharmaceuticals US (APUS) Edges Higher, Testing Key Resistance at $1.74Late Stage Breakouts - careplusvn.com
Sungjoon Chae appointed to Apimeds Pharmaceuticals US board; serves as Co‑CEO - TradingView
Co-CEO joins new 4-person board at Apimeds (APUS) - Stock Titan
Apimeds Pharmaceuticals US Acquires Apitox Royalty and Market Rights From FreeT to Advance U.S. Program - TradingView
Apimeds Pharmaceuticals US to implement 1-for-10 reverse stock split, new CUSIP 03771D201 - TradingView
Apimeds Pharmaceuticals US, Inc. Stock (APUS) Financials Data
There is no financial data for Apimeds Pharmaceuticals US, Inc. (APUS). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.76%
4.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):